1 matches for your search in the start-up spotlight
rssWe are developing the first pro-drug platform on RNA level, targeting oncological, viral and genetic diseases. It is our mission to open a new chapter in treating diseases and to deliver so called selectively expressed RNAs (seRNAs) to patients. We have an ambitious pipeline that targets ...